Tylenol Debate, HPV Vaccination: The Week in Health
Home > Health > Weekly Roundups

Tylenol Debate, HPV Vaccination: The Week in Health

Share it!
Aura Moreno By Aura Moreno | Journalist & Industry Analyst - Wed, 09/24/2025 - 15:42
DIA assistant

This week, US President Donald Trump claimed that Tylenol use during pregnancy was linked to autism, but the World Health Organization (WHO) disputed the evidence. Meanwhile, Mexico’s 2025 Public Health Week exceeded national goals, highlighting the country’s progress in preventive health. 

In other news, early life care initiatives are advancing through specialized neonatal programs and physician training, while medicine supply reaches near-full coverage, though gaps persist due to supplier compliance issues. Meanwhile, Mexico extends its HPV vaccination campaign to boys, aiming to protect millions of children and adolescents nationwide.

This is The Week in Health!

Trump Links Tylenol to Autism; WHO Disputes Claims

US President Donald Trump has drawn attention to the use of Tylenol during pregnancy, suggesting a link to autism despite the absence of conclusive scientific evidence.

Mexico’s 2025 Public Health Week Surpasses Goals

Mexico’s Ministry of Health announced that the 2025 National Public Health Week, held on Sept. 6–13 across the country, closed with results that exceeded national targets. The initiative aimed to reach 20 million people nationwide through about 30,000 activities, but final figures showed that 35,668 activities were carried out, representing 118% of the original goal. 

Mexico Advances Early Life Care Initiatives

The National Institute of Perinatology (INPer) strengthens newborn and early childhood health with specialized neonatal care and physician training, aiming to fortify public health through preventive care. 

Mexico Reports Advances in Medicine Supply but Gaps Remain

The Ministry of Health reports near-full coverage in the distribution of medicines and medical supplies across major public health institutions, though authorities say that compliance issues among several suppliers continue to leave gaps in access.

Mexico Extends HPV Vaccination to Boys in 2025 Campaign

Mexico has launched its 2025 National Human Papillomavirus (HPV) Vaccination Campaign, extending coverage to boys for the first time, as part of an effort to immunize more than 2.5 million children and adolescents across the country. The initiative began in Tlaxcala and is being led by the Ministry of Health.¿

You May Like

Most popular

Newsletter